{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:53:30Z","timestamp":1788821610533,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260612"],"award-info":[{"award-number":["82260612"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cuiying Scientific Training Program for Undergraduates of the Second Hospital & Clinical Medical School, Lanzhou University","award":["CYXZ2022-36"],"award-info":[{"award-number":["CYXZ2022-36"]}]},{"name":"Fundamental Research Funds for the Central Universities of Lanzhou University","award":["lzujbky-2022-sp08"],"award-info":[{"award-number":["lzujbky-2022-sp08"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16610-4","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T02:59:14Z","timestamp":1756090754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The expression of transmembrane channel-like 5 in gastric cancer and its impact on tumor progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Yucai","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongjie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,25]]},"reference":[{"issue":"3","key":"16610_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"16610_CR2","first-page":"47","volume":"4","author":"B Han","year":"2024","unstructured":"Han, B. et al. Cancer incidence and mortality in China, 2022. J. Natl. Cancer Cent. 4(1), 47\u201353 (2024).","journal-title":"J. Natl. Cancer Cent."},{"issue":"19","key":"16610_CR3","doi-asserted-by":"publisher","first-page":"16193323","DOI":"10.3390\/cancers16193323","volume":"16","author":"G Basirinia","year":"2024","unstructured":"Basirinia, G. et al. Theranostic approaches for gastric cancer: An overview of in vitro and in vivo investigations. Cancers (Basel) 16(19), 16193323 (2024).","journal-title":"Cancers (Basel)"},{"issue":"5","key":"16610_CR4","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift, A. P., Wenker, T. N. & El-Serag, H. B. Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention. Nat. Rev. Clin. Oncol. 20(5), 338\u2013349 (2023).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"19","key":"16610_CR5","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.3390\/cancers16193337","volume":"16","author":"F Lordick","year":"2024","unstructured":"Lordick, F., Rha, S. Y., Muro, K., Yong, W. P. & LordickObermannov\u00e1, R. Systemic therapy of gastric cancer-state of the art and future perspectives. Cancers (Basel) 16(19), 3337 (2024).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"16610_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan, W. L., He, Y. & Xu, R. H. Gastric cancer treatment: Recent progress and future perspectives. J. Hematol. Oncol. 16(1), 57 (2023).","journal-title":"J. Hematol. Oncol."},{"issue":"10418","key":"16610_CR7","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","volume":"402","author":"YY Janjigian","year":"2023","unstructured":"Janjigian, Y. Y. et al. Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: Interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial. Lancet 402(10418), 2197\u20132208 (2023).","journal-title":"Lancet"},{"issue":"9","key":"16610_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41571-024-00924-9","volume":"21","author":"J Yoon","year":"2024","unstructured":"Yoon, J. & Oh, D. Y. HER2-targeted therapies beyond breast cancer\u2014an update. Nat. Rev. Clin. Oncol. 21(9), 675\u2013700 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"11","key":"16610_CR9","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/cac2.12214","volume":"41","author":"Z Peng","year":"2021","unstructured":"Peng, Z. et al. Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: A single-arm phase II study. Cancer Commun. (Lond.) 41(11), 1173\u20131182 (2021).","journal-title":"Cancer Commun. (Lond.)"},{"issue":"5","key":"16610_CR10","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/s41571-024-00874-2","volume":"21","author":"I Nakayama","year":"2024","unstructured":"Nakayama, I. et al. Claudin 182 as a novel therapeutic target. Nat. Rev. Clin. Oncol. 21(5), 354\u2013369 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"16610_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41575-022-00703-w","volume":"20","author":"M Alsina","year":"2023","unstructured":"Alsina, M., Arrazubi, V., Diez, M. & Tabernero, J. Current developments in gastric cancer: From molecular profiling to treatment strategy. Nat. Rev. Gastroenterol. Hepatol. 20(3), 155\u2013170 (2023).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"16610_CR12","doi-asserted-by":"publisher","first-page":"715508","DOI":"10.3389\/fimmu.2021.715508","volume":"12","author":"J Song","year":"2021","unstructured":"Song, J. et al. Pan-cancer analysis reveals the signature of TMC family of genes as a promising biomarker for prognosis and immunotherapeutic response. Front Immunol. 12, 715508 (2021).","journal-title":"Front Immunol."},{"issue":"2","key":"16610_CR13","first-page":"244","volume":"7","author":"P Lu","year":"2017","unstructured":"Lu, P. et al. Transmembrane channel-like protein 8 as a potential biomarker for poor prognosis of hepatocellular carcinoma. Mol. Clin. Oncol. 7(2), 244\u2013248 (2017).","journal-title":"Mol. Clin. Oncol."},{"key":"16610_CR14","doi-asserted-by":"publisher","first-page":"810864","DOI":"10.3389\/fmolb.2021.810864","volume":"8","author":"H Zhang","year":"2021","unstructured":"Zhang, H., Zhang, X., Xu, W. & Wang, J. TMC5 is highly expressed in human cancers and corelates to prognosis and immune cell infiltration: A comprehensive bioinformatics analysis. Front Mol. Biosci. 8, 810864 (2021).","journal-title":"Front Mol. Biosci."},{"issue":"165","key":"16610_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.biochi.2019.07.017","volume":"2019","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Transmembrane Channel-Like 5 (TMC5) promotes prostate cancer cell proliferation through cell cycle regulation. Biochimie 2019(165), 115\u2013122 (2019).","journal-title":"Biochimie"},{"issue":"8","key":"16610_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.3748\/wjg.v26.i8.789","volume":"26","author":"L Pan","year":"2020","unstructured":"Pan, L. et al. Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma. World J. Gastroenterol. 26(8), 789\u2013803 (2020).","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"16610_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12943-019-1066-3","volume":"18","author":"Y Li","year":"2019","unstructured":"Li, Y. et al. Molecular characterization and clinical relevance of m(6)A regulators across 33 cancer types. Mol. Cancer 18(1), 137 (2019).","journal-title":"Mol. Cancer"},{"issue":"1","key":"16610_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","volume":"19","author":"B Zhang","year":"2020","unstructured":"Zhang, B. et al. m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol. Cancer 19(1), 53 (2020).","journal-title":"Mol. Cancer"},{"issue":"21","key":"16610_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.omtn.2020.06.001","volume":"2020","author":"L Yi","year":"2020","unstructured":"Yi, L., Wu, G., Guo, L., Zou, X. & Huang, P. Comprehensive analysis of the PD-L1 and immune infiltrates of m(6)A RNA methylation regulators in head and neck squamous cell carcinoma. Mol. Ther. Nucleic Acids 2020(21), 299\u2013314 (2020).","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"16610_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2478\/jtim-2023-0103","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. N(6)-methylation in the development, diagnosis, and treatment of gastric cancer. J. Transl. Int. Med. 12(1), 5\u201321 (2024).","journal-title":"J. Transl. Int. Med."},{"issue":"10","key":"16610_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1002\/1878-0261.12557","volume":"13","author":"H Lian","year":"2019","unstructured":"Lian, H. et al. Integrative analysis of gene expression and DNA methylation through one-class logistic regression machine learning identifies stemness features in medulloblastoma. Mol. Oncol. 13(10), 2227\u20132245 (2019).","journal-title":"Mol. Oncol."},{"issue":"2","key":"16610_CR22","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M. et al. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell 173(2), 338-354.e315 (2018).","journal-title":"Cell"},{"issue":"D1","key":"16610_CR23","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han, Y. et al. TISCH2: Expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 51(D1), D1425-d1431 (2023).","journal-title":"Nucleic Acids Res."},{"issue":"14","key":"16610_CR24","doi-asserted-by":"publisher","first-page":"i436","DOI":"10.1093\/bioinformatics\/btz363","volume":"35","author":"G Sturm","year":"2019","unstructured":"Sturm, G. et al. Comprehensive evaluation of transcriptome-based cell-type quantification methods for immuno-oncology. Bioinformatics 35(14), i436\u2013i445 (2019).","journal-title":"Bioinformatics"},{"issue":"1","key":"16610_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li, B. et al. Comprehensive analyses of tumor immunity: Implications for cancer immunotherapy. Genome Biol. 17(1), 174 (2016).","journal-title":"Genome Biol."},{"issue":"1","key":"16610_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: Digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18(1), 220 (2017).","journal-title":"Genome Biol."},{"issue":"10","key":"16610_CR27","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24(10), 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"issue":"7","key":"16610_CR28","doi-asserted-by":"publisher","first-page":"101302","DOI":"10.1016\/j.isci.2020.101302","volume":"23","author":"Z Liu","year":"2020","unstructured":"Liu, Z. et al. Systematic analysis of the aberrances and functional implications of ferroptosis in cancer. iScience 23(7), 101302 (2020).","journal-title":"iScience"},{"issue":"11","key":"16610_CR29","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28(11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"2","key":"16610_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1053\/j.gastro.2024.07.001","volume":"168","author":"A Kalra","year":"2025","unstructured":"Kalra, A. & Meltzer, S. J. The role of DNA methylation in gastrointestinal disease: An expanded review of malignant and nonmalignant gastrointestinal diseases. Gastroenterology 168(2), 245\u2013266 (2025).","journal-title":"Gastroenterology"},{"issue":"3","key":"16610_CR31","doi-asserted-by":"publisher","first-page":"94091","DOI":"10.5306\/wjco.v16.i3.94091","volume":"16","author":"J Li","year":"2025","unstructured":"Li, J. et al. Transmembrane channel-like 5 drives hepatocellular carcinoma progression by regulating epithelial-mesenchymal transition. World J. Clin. Oncol. 16(3), 94091 (2025).","journal-title":"World J. Clin. Oncol."},{"issue":"11","key":"16610_CR32","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41419-018-0950-x","volume":"9","author":"S Chen","year":"2018","unstructured":"Chen, S. et al. MicroRNA-495\u20133p inhibits multidrug resistance by modulating autophagy through GRP78\/mTOR axis in gastric cancer. Cell Death Dis. 9(11), 1070 (2018).","journal-title":"Cell Death Dis."},{"key":"16610_CR33","doi-asserted-by":"publisher","first-page":"101125","DOI":"10.1016\/j.drup.2024.101125","volume":"77","author":"D Dong","year":"2024","unstructured":"Dong, D. et al. Cellular and molecular mechanisms of gastrointestinal cancer liver metastases and drug resistance. Drug Resist. Updat 77, 101125 (2024).","journal-title":"Drug Resist. Updat"},{"issue":"41","key":"16610_CR34","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1038\/s41388-023-02816-1","volume":"42","author":"XY Tan","year":"2023","unstructured":"Tan, X. Y. et al. WNT2-SOX4 positive feedback loop promotes chemoresistance and tumorigenesis by inducing stem-cell like properties in gastric cancer. Oncogene 42(41), 3062\u20133074 (2023).","journal-title":"Oncogene"},{"key":"16610_CR35","doi-asserted-by":"publisher","first-page":"101002","DOI":"10.1016\/j.drup.2023.101002","volume":"71","author":"P Xing","year":"2023","unstructured":"Xing, P. et al. Treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs. Drug Resist. Updat 71, 101002 (2023).","journal-title":"Drug Resist. Updat"},{"issue":"110","key":"16610_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2025.02.002","volume":"2025","author":"Z Cao","year":"2025","unstructured":"Cao, Z. et al. Reshaping the immune microenvironment and reversing immunosenescence by natural products: Prospects for immunotherapy in gastric cancer. Semin Cancer Biol. 2025(110), 1\u201316 (2025).","journal-title":"Semin Cancer Biol."},{"issue":"1","key":"16610_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12943-024-02179-5","volume":"23","author":"J Wei","year":"2024","unstructured":"Wei, J., Li, W., Zhang, P., Guo, F. & Liu, M. Current trends in sensitizing immune checkpoint inhibitors for cancer treatment. Mol. Cancer 23(1), 279 (2024).","journal-title":"Mol. Cancer"},{"issue":"3","key":"16610_CR38","first-page":"377","volume":"24","author":"NJ Bernard","year":"2023","unstructured":"Bernard, N. J. T cells last longer than mice. Nat. Immunol. 24(3), 377 (2023).","journal-title":"Nat. Immunol."},{"issue":"1","key":"16610_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40246-024-00631-7","volume":"18","author":"Y Ding","year":"2024","unstructured":"Ding, Y. et al. An investigation of the molecular characterization of the tripartite motif (TRIM) family and primary validation of TRIM31 in gastric cancer. Hum. Genom. 18(1), 77 (2024).","journal-title":"Hum. Genom."},{"issue":"1","key":"16610_CR40","doi-asserted-by":"publisher","first-page":"20099","DOI":"10.1038\/s41598-023-47139-z","volume":"13","author":"Q Feng","year":"2023","unstructured":"Feng, Q. et al. Tripartite motif 31 drives gastric cancer cell proliferation and invasion through activating the Wnt\/\u03b2-catenin pathway by regulating Axin1 protein stability. Sci. Rep. 13(1), 20099 (2023).","journal-title":"Sci. Rep."},{"issue":"9","key":"16610_CR41","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/1878-0261.12089","volume":"11","author":"J Ye","year":"2017","unstructured":"Ye, J. et al. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt\/\u03b2-catenin signaling pathway. Mol. Oncol. 11(9), 1208\u20131224 (2017).","journal-title":"Mol. Oncol."},{"key":"16610_CR42","doi-asserted-by":"publisher","first-page":"216796","DOI":"10.1016\/j.canlet.2024.216796","volume":"589","author":"Z Zhao","year":"2024","unstructured":"Zhao, Z. et al. Activation of the FOXM1\/ASF1B\/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer. Cancer Lett. 589, 216796 (2024).","journal-title":"Cancer Lett."},{"issue":"48","key":"16610_CR43","doi-asserted-by":"publisher","first-page":"e35408","DOI":"10.1097\/MD.0000000000035408","volume":"102","author":"C Zhao","year":"2023","unstructured":"Zhao, C., Zhou, J., Xing, J. & Yin, Q. ASF1B acted as a prognostic biomarker for stomach adenocarcinoma. Med. (Baltim.) 102(48), e35408 (2023).","journal-title":"Med. (Baltim.)"},{"issue":"6","key":"16610_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3892\/ol.2023.13828","volume":"25","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway. Oncol. Lett. 25(6), 242 (2023).","journal-title":"Oncol. Lett."},{"issue":"6","key":"16610_CR45","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.7150\/jca.69544","volume":"13","author":"C Chen","year":"2022","unstructured":"Chen, C. et al. ASF1b is a novel prognostic predictor associated with cell cycle signaling pathway in gastric cancer. J. Cancer 13(6), 1985\u20132000 (2022).","journal-title":"J. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16610-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16610-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T13:53:24Z","timestamp":1757426004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16610-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16610"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16610-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,25]]},"assertion":[{"value":"16 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31168"}}